Clinical Trial: Neurology

Imperative

Full Name

A prospective, multi-center, open label and single arm clinical investigation to evaluate the safety and efficacy of using the Zoom Reperfusion System in thrombectomy procedures to treat acute ischemic stroke patients

Description

When a patient presents with stroke symptoms, they will be evaluated to see if they will need a thrombectomy. Thrombectomies are procedures where a small wire and suction tube is placed in an artery in the brain in an attempt to remove a clot which is blocking blood flow to the brain. There are several devices available on the market for this procedure, including the one for the study. If a patient consents, the doctors will use this device before choosing any other. Patients will be followed during their hospitalization to evaluate their progress and will return for a 90 day visit in the office.

Purpose

To determine if a device, which already has approval by the FDA for specific regions of the brain, can safely be used in additional regions. 

Eligibility

Inclusion Criteria

Inclusion Criteria-including but may not be limited to:

  • Age 18 and older
  • Ischemic stroke caused by large vessel occlusion
  • No recent stroke history or significant effects from any prior stroke

To Participate

Please contact the Network Office of Research and Innovation at 610-402-9543.

For additional information

https://www.clinicaltrials.gov/ct2/show/NCT04129125?term=Imperative&cond=Ischemic+Stroke&draw=2&rank=1
 

Doctor(s) Running This Study